Cargando…
Cost–Utility Analysis of a Medication Adherence Management Service Alongside a Cluster Randomized Control Trial in Community Pharmacy
BACKGROUND: It is necessary to determine the cost utility of adherence interventions in chronic diseases due to humanistic and economic burden of non-adherence. PURPOSE: To evaluate, alongside a cluster-randomized controlled trial, the cost-utility of a pharmacist-led medication adherence management...
Autores principales: | Valverde-Merino, Maria-Isabel, Martinez-Martinez, Fernando, Garcia-Mochon, Leticia, Benrimoj, Shalom I, Malet-Larrea, Amaia, Perez-Escamilla, Beatriz, Zarzuelo, Maria Jose, Torres-Robles, Andrea, Gastelurrutia, Miguel Angel, Varas-Doval, Raquel, Peiro Zorrilla, Tamara, Garcia-Cardenas, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554318/ https://www.ncbi.nlm.nih.gov/pubmed/34729007 http://dx.doi.org/10.2147/PPA.S330371 |
Ejemplares similares
-
Evaluating an implementation programme for medication review with follow-up in community pharmacy using a hybrid effectiveness study design: translating evidence into practice
por: Varas-Doval, Raquel, et al.
Publicado: (2020) -
Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial
por: Torres-Robles, Andrea, et al.
Publicado: (2022) -
A cost utility analysis alongside a cluster-randomised trial evaluating a minor ailment service compared to usual care in community pharmacy
por: Amador-Fernández, Noelia, et al.
Publicado: (2021) -
Systematic review of pragmatic randomised control trials assessing the effectiveness of professional pharmacy services in community pharmacies
por: Varas-Doval, R., et al.
Publicado: (2021) -
Clinical impact of a pharmacist-led medication review with follow up
for aged polypharmacy patients: A cluster randomized controlled
trial
por: Varas-Doval, Raquel, et al.
Publicado: (2020)